PDCD1 and nonpapillary renal cell carcinoma: PD-1 expression was increased in both ccRCC—Caki-1 (24–36 μg/mL) and RCC31 (24–48 μg/mL) cells and was decreased with the highest nivolumab concentrations, while in pRCCs was increased.